kabutan

Oncolys BioPharma, Last Fiscal Year's Net Income Loss Widens, Current period performance is undisclosed.

Fri Feb 6, 2026 3:00 pm JST Earnings

4588 Oncolys BioPharma Inc. 【J-GAAP】

Earnings Report

Oncolys BioPharma Inc. <4588> [TSE Growth] announced its financial results in the afternoon session on February 6th (15:00). The net loss (non-consolidated) for the fiscal year ended December 2025 expanded to a loss of 2.05 billion yen (compared to a loss of 1.68 billion yen in the previous period). This marks the fourteenth consecutive term of losses. Furthermore, the company did not disclose the performance outlook for the fiscal year ending December 2026.

In the most recent three-month period, from October to December (4Q), the net loss expanded to loss of 0.44 billion yen (compared to a loss of 0.43 billion yen in the same period last year).

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2023 63 -1,929 -1,913 -1,938 -108.9 0 Feb 9, 2024 J-GAAP
Dec, 2024 31 -1,681 -1,663 -1,684 -77.2 0 Feb 7, 2025 J-GAAP
Dec, 2025 28 -2,024 -2,051 -2,058 -80.0 0 Feb 6, 2026 J-GAAP
YoY -9.7% -20.4% -23.3% -22.2% -3.7%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2025 Guidance ー ー ー ー － 0 Feb 7, 2025 J-GAAP
Dec, 2025 Results 28 -2,024 -2,051 -2,058 -80.0 0 Feb 6, 2026 J-GAAP
Revision Rate － － － － －

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jan - Jun, 2025 28 -1,267 -1,311 -1,313 -52.9 0 Aug 8, 2025 J-GAAP
Jan - Jun, 2026 Guidance ー ー ー ー － 0 Feb 6, 2026 J-GAAP
YoY － － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2024 31 -1,681 -1,663 -1,684 -77.2 0 Feb 7, 2025 J-GAAP
Dec, 2025 28 -2,024 -2,051 -2,058 -80.0 0 Feb 6, 2026 J-GAAP
Dec, 2026 Guidance ー ー ー ー － 0 Feb 6, 2026 J-GAAP
YoY － － － － －

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2024 0 -451 -420 -438 -20.1 -Inf Feb 7, 2025 J-GAAP
Jan - Mar, 2025 0 -785 -810 -811 -32.7 -Inf May 9, 2025 J-GAAP
Apr - Jun, 2025 28 -482 -501 -502 -20.2 -1,721.4 Aug 8, 2025 J-GAAP
Jul - Sep, 2025 0 -304 -303 -304 -12.2 -Inf Nov 7, 2025 J-GAAP
Oct - Dec, 2025 0 -453 -437 -441 -17.1 -Inf Feb 6, 2026 J-GAAP
YoY － -0.4% -4.0% -0.7% +14.6%

Related Articles